Browse every story filed under this topic, curated from trusted publishers around the world.
White House to appeal ruling blocking vaccine schedule changes
The Trump administration has filed notice that it will appeal a federal court ruling that blocked changes to the U.S. childhood vaccine schedule, the latest turn in an ongoing legal and regulatory battle over the CDC’s …
Read full story →
Suffer from a blocked nose? Experts urge sufferers to avoid this common mistake that could be making it worse
The Medicines and Healthcare products Regulatory Agency (MHRA) has limited the use of certain nasal decongestant sprays to a maximum …
Congress, close the crypto crime gap — before criminals get there first
Americans lost nearly $21 billion to fraud last year, with cryptocurrency-related scams accounting for the largest share of losses, highlighting …
Consumer health data’s regulatory patchwork is growing. Relief isn’t coming.
Healthcare organizations are struggling to navigate the compliance landscape amid a pullback in federal enforcement, a wave of state legislation …
Axoft Secures $55M for Implantable Brain-Computer Interfaces and Fleuron™ Material Global Trials
What You Should Know Axoft has raised an oversubscribed $55M Series A led by C.P. Group Innovation, bringing its total …
Inside the booming, gray-market world of injectable peptides
Injectable peptides are all the rage for many health-conscious Americans, thanks in part to the hype coming from the nation’s …
Healthcare AI Governance: Implementing NIST Trustworthy AI and OWASP Security Guardrails
In Part 1 of this series, we covered the foundation of an AI-ready healthcare organization: an organization-appropriate governance framework, regulatory …
Healthcare Investment Banking: 2026 M&A Themes & Outlook
Stout is pleased to share its Healthcare Investment Banking: 2026 M&A Themes & Outlook. The full report covers key investment …
Regeneron's quarterly sales of Eylea drop below $1B for the first time in 8 years
As regulatory delays continue to plague Regeneron's Eylea franchise, quarterly sales for the eye disease medicine have dropped below $1 …
Health Care Service Corp. posts $1.9B loss in 2025
Health Care Service Corp. recorded a net loss of more than $1.9 billion in 2025, a sharp reversal from the …
AI-Driven Layoffs In Healthcare: Navigating Legal Risks and Operational Challenges
Layoffs tied to AI adoption will not be uniform; they will vary by sector, job function, and regulatory exposure. Nowhere …
Baystate to acquire Trinity Health hospital
Springfield, Mass.-based Baystate Health has signed a definitive agreement to acquire a financially challenged hospital in the city from Hartford, …
Novartis stands by $5B Pluvicto goal despite European regulatory setback, bispecific competition
Novartis CEO Vas Narasimhan is doubling down on his $5 billion peak sales projection for Pluvicto, even as the company …
Implementing Title X: policy design, administration, and geographic access to care
Abstract Background Title X of the Public Health Service Act is a critical federal program—the only one dedicated exclusively to …
Israel's Regulatory Authority Approves Shekel-Pegged Stablecoin After Pilot on Solana Blockchain
Israel’s regulator has approved a shekel-pegged stablecoin by Bits of Gold after a two-year pilot. The BILS token will operate …
Veradermics’ stock grows on pivotal hair loss win
If approved, Veradermics' VDPHL01 could become the first hair loss drug to secure the regulatory go-ahead in nearly three decades. …
Canada's Bill C-25 Clears Key Vote as Government Moves to Block Crypto Political Donations
Canada has proposed a bill to ban political donations made using cryptocurrency as part of broader election finance reforms. The …
Accenture Ventures Invests in Iridius to Scale Compliant-by-Design AI for Life Sciences and Pharmaceuticals
What You Should Know Accenture Ventures has made a strategic investment in Iridius, an enterprise AI infrastructure company specializing in …
TytoCare Receives FDA De Novo Classification for Tyto Insights ENT Suite AI Image Analysis
What You Should Know TytoCare has received FDA De Novo classification for its Tyto Insights™ for ENT Suite, creating a …
Intellia’s Data Reveal Tees Up FDA Filing for CRISPR-Based In Vivo Gene-Editing Med
Intellia Therapeutics’ lonvo-z uses CRISPR to inactivate a gene in the liver to reduce levels of a protein key to …
You've seen all articles for #regulatory.
Check back
soon
for new stories.